What are the differential diagnoses for fever and rash in a patient with Hodgkin lymphoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Differential Diagnosis of Fever with Rash in Hodgkin Lymphoma Patients

In a patient with Hodgkin lymphoma presenting with fever and rash, you must immediately prioritize life-threatening infectious causes—particularly opportunistic infections if the patient is immunosuppressed from chemotherapy—while simultaneously considering drug reactions, disease-related manifestations, and other malignancies.

Critical Initial Considerations

The clinical context determines your diagnostic approach. B symptoms (fever >38°C, night sweats, weight loss >10% in 6 months) are common in Hodgkin lymphoma itself 1, but the addition of rash significantly narrows your differential and demands urgent evaluation for infectious and drug-related etiologies that carry high morbidity and mortality.

Primary Differential Diagnoses

1. Infectious Causes (Highest Priority)

If the patient is receiving or has recently received chemotherapy (especially ABVD or BEACOPP regimens), opportunistic infections are your primary concern 2:

  • Bacterial infections: Particularly gram-negative sepsis in neutropenic patients (CD4+ <200 cells/μL)
  • Viral infections:
    • Epstein-Barr virus (EBV)—present in 90% of HIV-associated HL cases 2 and can cause infectious mononucleosis-like syndrome
    • Varicella-zoster virus (VZV) reactivation
    • Cytomegalovirus (CMV)
  • Fungal infections: Disseminated candidiasis, aspergillosis
  • Pneumocystis jirovecii pneumonia (PJP): Consider if CD4+ <200 cells/μL 2
  • Mycobacterial infections: Tuberculosis must be considered, especially in endemic areas 2

Key point: In HIV-positive patients with Hodgkin lymphoma, B symptoms should always prompt investigation for opportunistic infections before attributing them solely to lymphoma 2.

2. Drug Reactions

Chemotherapy-related cutaneous reactions are common:

  • Bleomycin: Can cause flagellate hyperpigmentation, erythema, and pulmonary toxicity
  • Doxorubicin: Radiation recall dermatitis, palmar-plantar erythrodysesthesia
  • Hypersensitivity reactions: To any component of ABVD, BEACOPP, or brentuximab vedotin regimens 3

3. Disease-Related Manifestations

Direct lymphoma involvement of skin is rare but documented 4:

  • Cutaneous granulomas: Can be the first manifestation of Hodgkin disease, presenting with fever, rash, and hepatomegaly 4
  • Specific cutaneous infiltration: Extremely rare but possible
  • Paraneoplastic phenomena: Pruritus (common in HL) 5, but rash is less typical

4. Other Malignancies

In patients with known Hodgkin lymphoma, consider:

  • Secondary lymphomas: Particularly in HIV-positive patients who have higher rates of non-Hodgkin lymphoma
  • Kaposi sarcoma: If HIV-positive 2

5. Inflammatory/Autoimmune Conditions

  • Drug-induced lupus: From procarbazine or other agents
  • Vasculitis: Can be triggered by infection or drugs

Diagnostic Algorithm

Step 1: Assess Immunosuppression Status

  • Check CD4+ count if HIV-positive or recent chemotherapy
  • If CD4+ <200 cells/μL: Assume opportunistic infection until proven otherwise 2
  • If CD4+ <100 cells/μL: Consider dose reduction in chemotherapy and prophylactic antibiotics 2

Step 2: Characterize the Rash Morphology

Following established fever-rash classification 6:

  • Maculopapular: Viral exanthems, drug reactions
  • Petechial/purpuric: Meningococcemia, disseminated intravascular coagulation, thrombocytopenia
  • Vesiculobullous: VZV, HSV, drug reactions
  • Diffuse erythema with desquamation: Toxic shock syndrome, drug reaction
  • Nodular: Fungal infections, cutaneous lymphoma 4

Step 3: Immediate Laboratory Evaluation

  • Complete blood count with differential: Assess for neutropenia, thrombocytopenia
  • Blood cultures: Before antibiotics if febrile
  • Procalcitonin (PCT) and serum amyloid A (SAA): Elevated levels favor bacterial infection over lymphoma 7
  • Albumin: Low levels associated with benign processes 7
  • Lactate dehydrogenase (LDH): Elevated in lymphoma and hemophagocytic syndromes
  • Liver function tests: Hepatic involvement common in disseminated disease 4

Step 4: Imaging

  • PET/CT if not recently performed: Can distinguish lymphoma from benign lymphadenopathy 7
    • SUVmean and total metabolic tumor volume (TMTV) are independent predictors: higher values favor lymphoma over benign causes 7
  • Chest imaging: Rule out pulmonary involvement (infection vs. lymphoma)

Step 5: Tissue Diagnosis

Skin biopsy is essential when diagnosis remains unclear 4:

  • Send for histology, immunohistochemistry, and cultures (bacterial, fungal, mycobacterial)
  • Look for Reed-Sternberg cells if lymphoma involvement suspected 4
  • Granulomatous infiltration may indicate either infection or lymphoma 4

Critical Management Decisions

Empiric Therapy Considerations

If neutropenic (ANC <500) or CD4+ <200 with fever:

  • Start broad-spectrum antibiotics immediately (anti-pseudomonal coverage)
  • Add PJP prophylaxis if CD4+ <200 and not already on prophylaxis 2
  • Consider antifungal coverage if persistent fever after 3-5 days of antibiotics

If rash suggests drug reaction:

  • Hold suspected agent (especially bleomycin if pulmonary symptoms present) 2
  • Consider corticosteroids for severe reactions

If lymphoma progression suspected:

  • Urgent chemotherapy may be indicated, particularly if patient is clinically unstable 8

Common Pitfalls to Avoid

  1. Attributing all fever to lymphoma without ruling out infection: B symptoms overlap significantly with infectious presentations 2, 6

  2. Overlooking drug reactions: Chemotherapy agents have multiple cutaneous toxicities that can mimic infection

  3. Failing to recognize granulomatous skin infiltration: This rare presentation of Hodgkin disease can be mistaken for infection 4

  4. Not checking HIV status: HIV-positive patients with HL have distinct presentations and higher infection risk 2

  5. Delaying skin biopsy: When diagnosis is unclear, tissue diagnosis is essential and should not be delayed 4

  6. Ignoring PET/CT metabolic parameters: Integration of SUVmean, TMTV with clinical parameters (rash, PCT, SAA) significantly improves diagnostic accuracy in distinguishing lymphoma from benign causes 7

Special Populations

HIV-Positive Patients with Hodgkin Lymphoma

  • 90% are EBV-associated 2
  • More commonly present with mixed cellularity or lymphocyte-depleted histologies 2
  • Higher rates of extranodal disease and bone marrow involvement 2
  • Require prophylaxis for opportunistic infections if CD4+ <200 cells/μL 2
  • Growth factors may be required despite concerns about bleomycin toxicity 2

Elderly Patients

  • Higher risk of treatment-related complications
  • More likely to have comorbidities affecting differential diagnosis
  • Consider less intensive chemotherapy regimens 9

References

1
Guideline

hodgkin lymphoma version 1.2017, nccn clinical practice guidelines in oncology.

Journal of the National Comprehensive Cancer Network : JNCCN, 2017

2
Guideline

cancer in people living with hiv, version 1.2018, nccn clinical practice guidelines in oncology.

Journal of the National Comprehensive Cancer Network : JNCCN, 2018

3
Guideline

hodgkin lymphoma, version 2.2015.

Journal of the National Comprehensive Cancer Network : JNCCN, 2015

4
Research

Cutaneous granulomas as the first manifestation of Hodgkin's disease.

European journal of dermatology : EJD, 2003

6
Research

Evaluating the febrile patient with a rash.

American family physician, 2000

Related Questions

What is the most common subtype of classical Hodgkin lymphoma?
In a 45-year-old man with stage II diffuse large B-cell lymphoma receiving chemotherapy (second cycle completed one week ago) who now has a fever (temperature 100.2°F decreasing to 99°F) and an absolute neutrophil count of 1,000 cells/µL with normal renal and hepatic function, what is the recommended management?
What is the appropriate evaluation and management for a 5-year-old girl presenting with fever and a maculopapular rash involving the legs and the soles of her feet?
What is the differential diagnosis and recommended management for a blanching rash?
What is the most likely diagnosis for a patient with a three‑day fever, posterior‑auricular lymphadenopathy, and a maculopapular rash that appears as the fever resolves, beginning on the back and spreading to the abdomen?
What is the preoperative risk assessment for an 87-year-old female with hypertension, a grade 3 systolic murmur (mitral valve disease), and left-sided pneumonia undergoing wide excision with possible split-thickness skin graft of the left leg?
In a patient with a large pericardial effusion, what is the role of furosemide and what is the appropriate dosing regimen?
What is the appropriate postoperative management and surveillance plan for a 2.7 cm Leydig‑cell tumor of the testis confined to the parenchyma with marked nuclear atypia, focal necrosis, and no lymph‑vascular invasion, rete testis involvement, or epididymal infiltration?
How should cefdinir be dosed for outpatient treatment of community-acquired pneumonia in adults and children?
Can azithromycin and doxycycline be administered together for the treatment of gonorrhea?
What is the clinical significance of a total cholesterol level of 114 mg/dL in a generally healthy adult without cardiovascular disease or other risk factors?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.